Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years old who are being treated at the CHU of Tours hospital
- People who have been diagnosed with rheumatoid arthritis (RA) according to recognised international classification standards, regardless of how long ago they were diagnosed
- People who have had, or are scheduled to have, a chest CT scan and breathing function tests done as part of their normal medical care, either up to 6 months before or after joining the study
- People who have at least two of the following risk factors for developing lung complications related to RA:
- Being male
- Being a current or former smoker with a significant smoking history (at least 20 pack-years)
- Being over 60 years old
- Having high levels of certain RA-related proteins in the blood (rheumatoid factor or anti-CCP antibodies) at any point during their illness
- Having high RA disease activity based on a standard scoring tool (DAS28 score above 3.2)
Who may not be able to join:
- People who have been diagnosed with a congenital (present from birth) lung condition
- People who have another autoimmune condition alongside RA that is also known to affect the lungs — such as systemic sclerosis, myositis, dermatomyositis, lupus, or certain types of vasculitis (note: secondary Sjögren's syndrome is an exception and does not automatically exclude someone — confirm with trial site)
- People who currently have, or have been treated for, lung cancer
- People who have had radiation treatment to the chest
- People who have had a chest or lung transplant
- People who have previously had invasive surgical procedures involving the chest
- People with certain conditions that cause thickening of the lining around the lungs, such as silicosis, asbestosis, known pleural plaques, or lung scarring from tuberculosis
- Women who are pregnant or breastfeeding
- People who are under a legal protection order, such as guardianship or court-appointed oversight
- People who have objected to their data being used in the study
- People who currently have, or have had within the past month, an active lung infection at the time of the ultrasound examination
- People who have fluid or air build-up around the lungs
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sylvie LEGUE, University Hospital, Tours
Phone: 0247479835
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Determination sensitivity and specificity of thoracic ultrasound
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.